Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)

Vivaldi, G; Jolliffe, DA; Holt, H; Tydeman, F; Talaei, M; Davies, GA; Lyons, RA; Griffiths, CJ; Kee, F; Sheikh, A; Shaheen, SO; Martineau, AR

View/Open

Accepted version (269.5Kb)

Volume

DOI

10.1016/j.lanepe.2022.100501

Journal

LANCET REGIONAL HEALTH-EUROPE

ISSN

2666-7762

Metadata

Show full item record

Authors

Vivaldi, G; Jolliffe, DA; Holt, H; Tydeman, F; Talaei, M; Davies, GA; Lyons, RA; Griffiths, CJ; Kee, F; Sheikh, A

URI

https://qmro.qmul.ac.uk/xmlui/handle/123456789/80530

Collections

Centre for Immunobiology [1053]

Licence information

This item is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.